News Daily News New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration L.A. McKeown December 18, 2018
News Daily News Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD L.A. McKeown December 17, 2018
News Daily News Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say L.A. McKeown December 07, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News TCT 2018 Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released Todd Neale September 24, 2018
News Conference News TCT 2018 IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease Todd Neale September 22, 2018
News Daily News RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease L.A. McKeown May 08, 2018
News Daily News Same-Day Discharge After Peripheral Interventions Gets Mixed Results in Pilot Study Todd Neale March 22, 2018
News Conference News ACC 2018 COMPASS Approach Helps With Leg Complications in Patients With PAD Todd Neale March 12, 2018
Presentation ACC 2018 High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS Presenter: Sonia S. Anand March 11, 2018
News Conference News ISET 2018 Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’ Caitlin E. Cox February 05, 2018